| Literature DB >> 34143250 |
Ursula Kassner, Stefanie Grunwald, Dominik Spira, Nikolaus Buchmann, Thomas Bobbert, Elisabetta Gazzerro, Tim Hollstein, Simone Spuler, Elisabeth Steinhagen-Thiessen1.
Abstract
Statins are among the most frequently prescribed drugs in Germany. Their benefits in lowering cardiovascular risk are beyond dispute. Nevertheless, many patients complain of side effects from statin therapy, including statin-associated muscle symptoms (SAMS) in particular. Despite their relative frequency, it is difficult to objectively diagnose them, as the time until appearance of first symptoms, the nature of the complaints and the severity of muscle problems vary widely. This narrative review summarizes the causes of SAMS as well as new possibilities regarding their diagnosis and therapy.Entities:
Keywords: Creatine kinase; Genetic predisposition to disease; HMG CoA reductase; Myalgia; Myopathies
Mesh:
Substances:
Year: 2021 PMID: 34143250 DOI: 10.1007/s00108-021-01059-0
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743